Cargando…
A Novel ARMC5 Germline Variant in Primary Macronodular Adrenal Hyperplasia Using Whole-Exome Sequencing
Background: Primary macronodular adrenocortical hyperplasia (PMAH) is a rare form of adrenal Cushing’s syndrome with incomplete penetrance which may be sporadic or autosomal dominant. The inactivation of the ARMC5 gene, a potential tumor suppressor gene, is one of the associated causes of PMAH. This...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777150/ https://www.ncbi.nlm.nih.gov/pubmed/36553033 http://dx.doi.org/10.3390/diagnostics12123028 |
_version_ | 1784856033158496256 |
---|---|
author | Eghbali, Maryam Cheraghi, Sara Samanian, Sara Rad, Iman Meghdadi, Jafar Akbari, Hamideh Honardoost, Maryam |
author_facet | Eghbali, Maryam Cheraghi, Sara Samanian, Sara Rad, Iman Meghdadi, Jafar Akbari, Hamideh Honardoost, Maryam |
author_sort | Eghbali, Maryam |
collection | PubMed |
description | Background: Primary macronodular adrenocortical hyperplasia (PMAH) is a rare form of adrenal Cushing’s syndrome with incomplete penetrance which may be sporadic or autosomal dominant. The inactivation of the ARMC5 gene, a potential tumor suppressor gene, is one of the associated causes of PMAH. This study aimed to identify the variant responsible for Iranian familial PMAH. Methods: The proband, a 44-year-old woman, was directed to whole-exome sequencing (WES) of the blood sample to discover a germline variant. In addition, the identified causative variant was confirmed and segregated in other and available unaffected family members. Results: The novel germline heterozygous missense variant, c.2105C>A in the ARMC5 gene, was found, and the same germline variant as the proband was confirmed in two affected sisters. This variant was detected in the brother of the proband with an asymptomatic condition and this considered because of incomplete penetrance and age-dependent appearance. The function of the ARMC5 protein would be damaged by the identified variant, according to in silico and computer analyses that followed. Conclusion: The new germline ARMC5 variation (c.2105C>A, (p. Ala702Glu)) was interpreted as a likely pathogenic variant based on ACMG and Sherloc standards. PMAH may be diagnosed early using genetic testing that shows inherited autosomal dominant mutations in the ARMC5 gene. |
format | Online Article Text |
id | pubmed-9777150 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97771502022-12-23 A Novel ARMC5 Germline Variant in Primary Macronodular Adrenal Hyperplasia Using Whole-Exome Sequencing Eghbali, Maryam Cheraghi, Sara Samanian, Sara Rad, Iman Meghdadi, Jafar Akbari, Hamideh Honardoost, Maryam Diagnostics (Basel) Article Background: Primary macronodular adrenocortical hyperplasia (PMAH) is a rare form of adrenal Cushing’s syndrome with incomplete penetrance which may be sporadic or autosomal dominant. The inactivation of the ARMC5 gene, a potential tumor suppressor gene, is one of the associated causes of PMAH. This study aimed to identify the variant responsible for Iranian familial PMAH. Methods: The proband, a 44-year-old woman, was directed to whole-exome sequencing (WES) of the blood sample to discover a germline variant. In addition, the identified causative variant was confirmed and segregated in other and available unaffected family members. Results: The novel germline heterozygous missense variant, c.2105C>A in the ARMC5 gene, was found, and the same germline variant as the proband was confirmed in two affected sisters. This variant was detected in the brother of the proband with an asymptomatic condition and this considered because of incomplete penetrance and age-dependent appearance. The function of the ARMC5 protein would be damaged by the identified variant, according to in silico and computer analyses that followed. Conclusion: The new germline ARMC5 variation (c.2105C>A, (p. Ala702Glu)) was interpreted as a likely pathogenic variant based on ACMG and Sherloc standards. PMAH may be diagnosed early using genetic testing that shows inherited autosomal dominant mutations in the ARMC5 gene. MDPI 2022-12-02 /pmc/articles/PMC9777150/ /pubmed/36553033 http://dx.doi.org/10.3390/diagnostics12123028 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Eghbali, Maryam Cheraghi, Sara Samanian, Sara Rad, Iman Meghdadi, Jafar Akbari, Hamideh Honardoost, Maryam A Novel ARMC5 Germline Variant in Primary Macronodular Adrenal Hyperplasia Using Whole-Exome Sequencing |
title | A Novel ARMC5 Germline Variant in Primary Macronodular Adrenal Hyperplasia Using Whole-Exome Sequencing |
title_full | A Novel ARMC5 Germline Variant in Primary Macronodular Adrenal Hyperplasia Using Whole-Exome Sequencing |
title_fullStr | A Novel ARMC5 Germline Variant in Primary Macronodular Adrenal Hyperplasia Using Whole-Exome Sequencing |
title_full_unstemmed | A Novel ARMC5 Germline Variant in Primary Macronodular Adrenal Hyperplasia Using Whole-Exome Sequencing |
title_short | A Novel ARMC5 Germline Variant in Primary Macronodular Adrenal Hyperplasia Using Whole-Exome Sequencing |
title_sort | novel armc5 germline variant in primary macronodular adrenal hyperplasia using whole-exome sequencing |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777150/ https://www.ncbi.nlm.nih.gov/pubmed/36553033 http://dx.doi.org/10.3390/diagnostics12123028 |
work_keys_str_mv | AT eghbalimaryam anovelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing AT cheraghisara anovelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing AT samaniansara anovelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing AT radiman anovelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing AT meghdadijafar anovelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing AT akbarihamideh anovelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing AT honardoostmaryam anovelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing AT eghbalimaryam novelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing AT cheraghisara novelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing AT samaniansara novelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing AT radiman novelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing AT meghdadijafar novelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing AT akbarihamideh novelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing AT honardoostmaryam novelarmc5germlinevariantinprimarymacronodularadrenalhyperplasiausingwholeexomesequencing |